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ABSTRACT
Elevated blood homocysteine (Hcy) level is frequently observed in aged individuals 
and those with age-related vascular diseases. However, its effect on peripheral 
microcirculation is still not fully understood. Using in vivo zebrafish model, the degree 
of Hcy-induced peripheral microcirculation dysfunction is assessed in this study with a 
proposed dimensionless velocity parameter V /VCV PCV , where VCV and VPCV represent 
the peripheral microcirculation perfusion and the systemic perfusion levels, respectively. 
The ratio of the peripheral microcirculation perfusion to the systemic perfusion is largely 
decreased due to peripheral accumulation of neutrophils, while the systemic perfusion 
is relatively preserved by increased blood supply from subintestinal vein. Pretreatment 
with L-arginine attenuates the effects of Hcy on peripheral microcirculation and reduces 
the peripheral accumulation of neutrophils. Given its convenience, high reproducibility 
of the observation site, non-invasiveness, and the ease of drug treatment, the present 
zebrafish model with the proposed parameters will be used as a useful drug screening 
platform for investigating the pathophysiology of Hcy-induced microvascular diseases.
INTRODUCTION
Homocysteine (Hcy) is a sulfur-containing 
amino acid and a byproduct of methionine metabolism. 
Elevated blood Hcy level (hyperhomocysteinemia) is 
frequently observed in aged individuals and those with 
age-related vascular diseases, including cardiovascular 
and cerebrovascular diseases [1]. A proposed mode of 
Hcy-induced vascular disease is to impair the endothelial 
synthesis of nitric oxide (NO) with subsequent onset 
of endothelial dysfunction that causes adherence of 
leukocytes to endothelial cells, activation of platelets, and 
inhibition of endothelium-mediated vasodilation [2–4].
In previous in vivo studies using mammalian animal 
models of rats and cynomolgus monkeys, diet-induced 
hyperhomocysteinemia was reported to reproduce the 
proposed Hcy-induced endothelial injuries and develop 
microvascular resistance from increased endothelial adherence 
by neutrophils [2, 5]. Specifically, the endothelial adherence 
by neutrophils upon hyperhomocysteinemia is accelerated by 
upregulating the P-selectin, L-selectin, intercellular adhesion 
molecule-1 (ICAM-1), and CD11b/CD18 [6, 7]. These results 
support the observed endothelial injuries and peripheral 
microcirculation dysfunction (PMD) development by the 
increased microvascular accumulation of neutrophils [8]. 
Unfortunately, the extent of PMD arising from such changes 
is only qualitatively investigated, because mammalian animal 
models require invasive measurement techniques and post-
mortem examinations [9]. Therefore, the development of a 
viable in vivo animal model that provides quantitive assessment 
of PMD would open new opportunities in the studies on 
microvascular diseases and corresponding drug screening.
Zebrafish (Danio rerio) as a vertebrate is an 
emerging disease model used for understanding human 
genetics and embryonic development due to its high 
similarity with human genome [10, 11]. Given its optical 
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transparency and hemodynamic analogy with human 
capillary networks, it has been also used as a non-invasive 
model for real-time in vivo investigation of cardiovascular 
morphologies and pathologies, including the angiogenic 
effects of elevated Hcy [12, 13].
In the present study, hemodynamic effects of Hcy 
treatment on microcirculation in zebrafish are experimentally 
investigated by a micro-particle imaging velocimetry 
(PIV) technique and digital motion analysis. The proposed 
dimensionless parameter V /VCV PCV is used as a quantitative 
measure of the PMD severity. In addition, the protective 
effect of L-arginine against Hcy-induced PMD is also 
examined in zebrafish models with the proposed parameter.
RESULTS
Selection of vessels and definition of velocity 
parameters
Schematic diagrams of the zebrafish vessel network 
are shown in Figure 1. A region of interest (ROI) in the 
dorsal aorta (DA) is designated behind the swim bladder 
from the first to the third segment of the bone. The time- 
averaged RBC velocity (VADA) and peak systolic RBC 
velocity (VPDA ) in the ROI of the DA are obtained by 
conditional phase averaging of data for 10 cardiac cycles. 
Veins are divided into the following three branches based 
on the location of the sphincter (black triangle): posterior 
cardinal vein (PCV), caudal vein (CV), and subintestinal vein 
(SIV). Similarly, the ROI in the PCV is designated at the left 
side of the sphincter where the bloods flowed from the CV 
and the SIV converge. Another ROI in the CV is designated 
at the right side of the sphincter. The time-averaged velocity 
of RBCs in the PCV and CV for 10 cardiac cycles is defined 
as VPCV  and VCV , respectively. The ROI in the SIV is 
designated under the PCV. These ROIs are marked by dotted 
boxes in the vessel diagram shown in Figure 1.
Hcy-induced PMD in zebrafish at 10 days post 
fertilization (dpf)
The degree of Hcy-induced PMD after 24 h of 
Hcy exposure is assessed by dimensionless parameters: 
V /VCV PCV, V / VCV ADA, V / VPCV PDA, and V / VPCV PDA. 
The biological significance of the four non-dimensional 
velocities of zebrafish microcirculation is summarized in 
Table 1.
Exposing zebrafish to the near-physiological 
concentration of 50 μM Hcy significantly reduces 
V /VCV PCV  from 0.560 to 0.432 (22.9%, p<0.05) (Figure 
2A). This result is corroborated by significant reduction 
in V / VCV ADA  from 0.277 to 0.139 (49.8%, p<0.05) 
Figure 1: Schematics of the vascular network of a 10 dpf zebrafish. Vessels are composed of the dorsal artery (DA), posterior 
cardinal vein (PCV), caudal vein (CV), and subintestinal vein (SIV). Each region of interest (ROI) is represented by dotted box. The time-
averaged RBC velocity and peak systolic RBC velocity in the DA are defined as VADA and VPDA , respectively. The time-averaged RBC 
velocities in the PCV and CV regions are defined as VPCV  and VCV , respectively.
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at the highest concentration of 500 μM Hcy (Figure 
2B). On the contrary, the dimensionless parameters 
representing systemic perfusion level show a little or no 
changes. V / VPCV PDA  is decreased from 0.500 to 0.349 
(30.2%, p>0.05) at the highest concentration (Figure 
2C). In addition, V / VPCV PDA  exhibits no change under 
the same conditions, except at the highest concentration 
(23.3%, p>0.05) (Figure 2D). These results suggest that 
Hcy treatment for 24 hr selectively reduces the level of 
peripheral microcirculation perfusion, and hence indicate 
the emergence of PMD. Meanwhile, the assessment 
of Reynolds (
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) at DA does not show significant 
changes over all Hcy doses tested in this study. They 
remain at comparable levels to those observed in human 
microcirculation. This implies that the rheological and 
blood flow characteristics are not significantly changed 
under the conditions in this study (Table 2).
Increase of number ratio of RBCs in the SIV
PMD occurrence is expected to increase blood flow 
in SIV to balance the reduced peripheral perfusion by 
virtues of the network Fahraeus effect and conservation 
requirement of RBCs in the closed circulatory system of 
zebrafish. This projection is checked by the changes in a 
dimensionless ratio, RBCSIV/RBCPCV, which is the ratio 
of RBCs passing through the center regions of the SIV 
to those of the PCV. The number of RBCs in each vein 
is evaluated by digital motion analysis technique [14]. 
RBCSIV/RBCPCV is significantly increased as a result of 
Hcy-induced PMD in the tail region according to Hcy 
level from 0.180 upto 0.382 at the highest Hcy dose (500 
μM) (p<0.05) (Figure 3).
Pretreatment with 50 μM L-arginine prevents 
Hcy-induced PMD
The compromised endothelial NO-synthesis was 
previously suggested as the vasotoxic mechanism of 
elevated Hcy [15]. In addition, administration with 
an L-arginine was reported to attenuate this effect by 
promoting endothelial NO synthesis [16]. Therefore, we 
investigate the attenuating effect of L-arginine treatment 
against the Hcy-induced PMD using a parameter 
V /VCV PCV . As shown in Figure 4, in the absence of 
L-arginine pretreatment, V /VCV PCV  is dramatically 
decreased from 0.582 to 0.378 upon exposure to100 μM 
Hcy (p<0.001). This effect is fully blocked by pretreatment 
with 50 μM L-arginine, which gives rise to a V /VCV PCV  
value of 0.585 (p<0.001) (Figure 4). Pretreatment 
with 10 μM L-arginine, on the other hand, results in an 
insignificant protective effect with a V /VCV PCV  value of 
0.412 (p>0.05). These results suggest that pretreatment 
with 50 μM L-arginine protects against the onset of 100 
μM Hcy-induced PMD, which is consistent with the 
previously reported protective effect of L-arginine against 
Hcy-induced vasotoxicity [16].
Reduction in peripheral neutrophil adherence 
is associated with the protective effect of 
L-arginine pretreatment against Hcy-induced 
PMD
Hcy-induced vasotoxicity results in the increased 
activation of neutrophils and subsequent adherence to 
vascular endothelium [2]. The increased adherence of 
neutrophils to microvessels contributes to Hcy-induced 
PMD through the volume-exclusion effect in Hcy-
exposed lumen [17]. Therefore, Hcy-induced neutrophil 
accumulation is examined by selective staining of 
neutrophils with Sudan Black B. Sudan Black B is a lipid 
staining agent that stains neutrophilic granules to positively 
identify neutrophils [18]. Application of this dye to post-
mortem specimens of the Hcy-exposed zebrafish reveals 
a higher number of stained neutrophils in and around the 
CV of their tail regions (black arrows), compared to those 
in the control zebrafish model (Figures 5A, 5B and 5D). 
A large majority of the neutrophils migrate into the CV, 
indicating their inflammatory activation. Given simplicity 
of the peripheral vascular structure of zebrafish tail region, 
Table 1: Biological significance of dimensionless velocities
Dimensionless velocity Biological meaning
V V/CV ADA
Relative peripheral microcirculation perfusion level versus systemic 
perfusion
V V/CV ADA
Relative peripheral microcirculation perfusion level versus average 
cardiac output
V / VPCV ADA
Relative systemic perfusion level versus average cardiac output
V / VPCV PDA
Relative systemic perfusion level versus peak cardiac output
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only a small number of neutrophils adhered to the CV is 
required for development of PMD. Therefore, the Hcy-
induced adherence of neutrophils is a contributing factor 
to Hcy-induced PMD. In support of this projection, the 
pretreatment with 50 μM L-arginine greatly reduces the 
accumulation of neutrophils in the CV region (Figures 5C 
and 5D). This result is consistent with the preventive effect 
of L-arginine pretreatment against the Hcy-induced PMD 
(Figure 4).
DISCUSSION
The proposed dimensionless parameter 
V /VCV PCV effectively characterizes Hcy-induced PMD 
in zebrafish. Peripheral microcirculation perfusion is 
selectively impaired relative to the systemic perfusion 
and the average cardiac output (Figures 2A and 2B). 
The dysfunction is also closely associated with the 
elevated peripheral accumulation of neutrophils 
(Figures 5B and 5D). This selective reduction in 
peripheral microcirculation is compensated by relative 
increase of the blood flow migrating from the SIV into 
the PCV (Figure 3). Furthermore, the pretreatment with 
50 μM L-arginine significantly attenuates the onset 
of PMD (Figure 4) and the subsequent accumulation 
of neutrophils in the peripheral CV (Figures 5C and 
5D). To the best of our knowledge, this is the first 
quantitative hemodynamic study on pathological 
effects of Hcy on the microcirculation of an intact in 
vivo disease model.
Figure 2: Hcy-induced PMD reduces blood flow in the CV. The minimum concentration of 50 μM Hcy greatly reduces (A) 
V /VCV PCV . Meanwhile, the highest concentration of 500 μM Hcy significantly reduces (B) V / VCV ADA. However, (C) V / VPCV PDA  
and (D) V / VPCV PDA do not noticeably change, indicating that systemic perfusion is relatively preserved. Asterisk (*) denotes significant 
decrease in peripheral microcirculation perfusion according to the level of Hcy-induced PMD, compared with the control. n=4-6 per Hcy 
group; * p<0.05 (one-way ANOVA with Newman-Keuls’s post-test). Resulting values are expressed as mean ± SD (standard deviation).











Reynolds number 0.0038±0.0012 0.0037±0.0014 0.0037±0.0007 0.0036±0.0006 0.0038±0.0012
Womersley number 0.011±0.0018 0.012±0.0021 0.012±0.0007 0.013±0.0024 0.013±0.0007
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The degree of Hcy-induced PMD is assessed using 
four dimensionless parameters with varying Hcy level. 
Among the four parameters, V /VCV PCV  represents 
the function of peripheral microcirculation perfusion 
conveniently and effectively (Figure 2A). While 
V / VCV ADA  also effectively indicates the Hcy-induced 
PMD at higher Hcy doses (Figure 2B), V /VCV PCV  better 
reflects the development of PMD for all doses of Hcy in 
this study. Furthermore, V /VCV PCV could be conveniently 
measured using only one ROI, while the evaluation of 
VADA  requires additional experimental techniques due 
to high-speed flow velocity and violent pulsatility at DA. 
On the other hand, V / VPCV PDA  values are not varied 
under the Hcy-exposure conditions, leading to decreased 
VPCV , while V / VPCV PDA  is decreased under the same 
condition. This result indicates that Hcy-exposure reduces 
the pulsatility of zebrafish heart with relatively less effect 
on the average cardiac output. This implies that the end 
diastolic velocity (VEDA ) in the DA would increase in 
response to Hcy exposure. These results suggest that high 
Figure 3: Variation in the number ratio of RBCs in the SIV and PCV regions. The number ratio of RBCs passing through the 
SIV (RBCSIV) relative to the PCV (RBCPCV) is increased with the elevation of Hcy level for maintaining systemic perfusion against Hcy-
induced PMD in the tail region. Asterisk (*) denotes significant increase in compensatory blood flow from the SIV. n = 4-6 per Hcy group; 
* p<0.05 (one-way ANOVA with Newman-Keuls’s post-test). Resulting values are expressed as mean ± SD (standard deviation).
Figure 4: Pretreatment with 50 μM L-arginine attenuates the onset of Hcy-induced PMD. The degree of PMD is assessed 
with the non-dimensional parameter V /VCV PCV . Asterisk (*) denotes the significant protective effect of L-arginine pretreatment against 
Hcy-induced PMD. n = 7–13 per group; ** p<0.01 and *** p<0.001 (one-way ANOVA with Newman-Keuls’s post-test). L-arg indicates 
L-arginine. Resulting values are expressed as mean ± SD (standard deviation).
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peripheral vascular resistance would decrease VPDA  while 
increasing the end-diastolic volume and its pressure to 
pump out, because most RBCs would circulate around 
the proximal vessels to the heart. Similarly, decrease of 
VPDA  and increase of VEDA  in the intracranial artery were 
reported in the early stage of fetal circulation [19].
The present results show that the accumulation 
of neutrophils predominantly occurs in and around the 
peripheral CV (Figure 5B). The CV has been known to be 
prone to leukocyte adherence, because it is characterized 
in the regions of low wall shear stress (WSS) [20]. 
Immunological behaviors of activated neutrophils, 
including rolling and adherence, are also frequently 
observed in the region with low WSS [21]. Acute exposure 
to Hcy activates the expression of adhesion molecules, 
such as P-selectin, ICAM-1, L-selectin, and CD11b/
CD18 [6, 7], which would cause exclusive accumulation 
of neutrophils in the region having those effects (Figure 
5B). Furthermore, the adherence of neutrophils in 
peripheral vascular lumen accelerates peripheral resistance 
by pseudopod formation that plugs capillaries and 
narrows lumens size by volume exclusion effect [17]. In 
addition, the increased interactions between the activated 
neutrophils and RBCs increase local blood viscosity 
in the region, further increasing flow resistance [22]. In 
these regards, the present observation of the Hcy-induced 
peripheral neutrophil accumulation in the CV explains 
the onset of PMD (Figures 5B and 5D), as well as the 
protective effect of L-arginine treatment (Figures 4, 5C 
and 5D).
Another interesting observation in this study is 
the compensatory increase of blood flow in the SIV 
relative to the systemic perfusion upon the onset of Hcy-
induced PMD. The reduced peripheral perfusion makes 
it possible to decrease the systemic perfusion based on 
the conservation of mass. However, systemic perfusion 
in the PCV is relatively preserved in a support of blood 
flow from the SIV (Figure 3), resulting in decrease of the 
V /VCV PCV  under PMD (Figure 2A). Isogai et al. (2001) 
examined vascular development in zebrafish model [23], 
and reported that its heart provides blood to the digestive 
organ via the supraintestinal artery and the SIV. This 
unique vascular network allows for direct circulation of 
blood flow from the heart to the PCV via the SIV, and 
hence makes the systemic perfusion preserved against 
PMD as long as the cardiac output is maintained.
In this study, we demonstrated unique advantages of 
zebrafish model in quantitative analysis of microvascular 
hemodynamic features, compared to conventional 
mammalian animal models. In addition to its ease of drug 
treatment and pathological assessment from its optical 
transparency, it also can be used as a reproducible platform 
for quantitative analysis of PMD. Specifically, while the 
vascular structures around the CV and PCV are highly 
consistent [12], the odd identification of the reproducible 
microvascular geometry with a consistent vasomotor 
response is nearly impossible in higher mammalian animal 
models [24]. In addition, since both VCV  and VPCV  can 
be non-invasively measured simultaneously in the same 
frame, zebrafish model has observational convenience for 
quantitative analysis of PMD. These advantages support 
that the present zebrafish model can be used as a potential 
high-throughput platform for drug screening against 
microvascular diseases.
Figure 5: Accumulation of neutrophils in the tail region. The stained neutrophils in the tail region of (A) control, (B) the 100 
μM Hcy-exposed, and (C) the 50 μM L-arginine pretreated 100 μM Hcy-exposed zebrafish are visualized. Arrows indicate significantly 
aggregated neutrophils. (D) The areas with accumulated neutrophils in the tail region are quantitatively compared. n = 5–12 per group; 
**p<0.01 and *** p<0.001 (one-way ANOVA with Newman-Keuls’s post-test). Control, control zebrafish without any treatment; Hcy, 




Zebrafish were provided by Korea Zebrafish 
Organogenesis Mutant Bank (Daegu, Korea). The 
specimens were raised in freshwater containing 0.1 mM 
phenylthiourea to inhibit the melanization of zebrafish 
embryos. Cultivation conditions were as follows: room 
temperature of 28.0±0.5 °C and 14 h:10 h light-dark cycle. 
The fish were fed thrice a day after five dpf. Experiments 
were performed with 8–10 dpf zebrafish. All experimental 
procedures were approved by the Animal Care and 
Ethics Committee of POSTECH and were performed in 
accordance with the approved guidelines.
Hcy-exposed zebrafish samples were prepared 
by administering 10, 50, 100, 200, or 500 μM D,L-
homocysteine solution (Sigma Aldrich, USA) to 9-dpf 
zebrafish for one day. To investigate the effect of NO 
against Hcy-induced PMD prior to Hcy treatment, 
L-arginine-pretreated zebrafish samples were prepared 
by administering 10 or 50 μM L-arginine solution (Sigma 
Aldrich, USA) to 8-dpf zebrafish for one day. A similar 
procedure was followed after L-arginine treatment.
Experimental setup
A 10-dpf zebrafish was anesthetized by short 
exposure to 0.02% tricaine and mounted on 5% 
methylcellulose. Velocity field information and the 
number of RBCs in vessels were measured with sequential 
images, which were captured by an inverted microscope 
(Zeiss Axiovert 200, Zeiss, Germany) with a 20× (NA = 
0.4) objective lens. The test vessel was illuminated with 
a halogen lamp. Sequential images were acquired in the 
center plane of the vessel by a high-speed CCD camera 
(Photron Ultima APX, Photron, Japan) at a frame rate 
of 125 fps. Image processing was performed with Image 
J software. All experiments were performed at room 
temperature (28 °C).
Micro-PIV measurement
The velocity of RBCs as trace particles was 
measured by a micro-PIV technique. Unlike conventional 
PIV techniques that utilize a laser, this study adopted 
volumetric illumination with a halogen lamp in a 
consideration of low-depth of focus of the microscope 
lens. Velocity field information was obtained by a FFT-
based cross-correlation PIV algorithm with a multigrid 
interrogation window of 64 ×16 pixels and 50% overlap. 
This technique can be applied to blood flows at high 
hematocrit levels to extract velocity vectors because each 
interrogation window should have at least several RBCs 
as tracer particles. Micro-PIV analysis was conducted with 
commercially available PIVview software (PIVview 2C, 
PIVTEC, Germany).
Digital motion analysis
Sequential images are composed of static and 
dynamic pixels. Gray scale values of static pixels 
remain constant in consecutive images, whereas those 
of dynamic pixels are altered by moving obstacles. 
Subtracting static pixels yields a gray scale value of 
zero, whereas subtracting dynamic pixels yields gray 
scale values of 1 to 255. The number of subtracted 
dynamic pixels caused by moving RBCs is used to 
visualize the spatial distribution of RBCs without 
background image and to measure the number of RBCs 
passing through the vessels. The detailed methodology 
of motion analysis is described in [14]. In contrast to the 
micro-PIV technique which requires flow images from 
blood with high hematocrit levels to obtain velocity 
field information, this motion analysis technique can 
analyze the flow characteristics of blood with both low 
and high hematocrit levels. The flow characteristics 
in the SIV at low hematocrit levels and in the PCV at 
high hematocrit levels were investigated using by this 
technique. The number of RBCs passing through the 
vessel was estimated at the center region of the vessel 
for 10 s. Digital image processing was conducted with 
MATLAB software (Mathworks, USA).
Staining of neutrophils with Sudan Black B
Briefly, 10 dpf zebrafish were fixed with 10% 
formalin overnight at 4 °C. The fish were washed thrice 
with PBS solution for 5 min and incubated in Sudan 
Black B solution (Sigma Aldrich, USA) following a 
previously reported procedure [18]. The neutrophils 
stained with a non-fluorescent dye were not clearly 
distinguished from unstained pigments around the 
vessels, which makes it difficult to use an automatic 
digital image processing technique. Thus, Image J 
software was employed to manually evaluate the 
accumulation areas of stained neutrophils in the tail 
region behind the sphincter.
Statistical analysis
Statistical analysis was conducted with GraphPad 
Prism 7 software (Graphpad Software Inc., USA). 
Statistical significance was analyzed using one-way 
ANOVA with Newman-Keuls’s post-test for multiple 
comparisons. Here, * indicates p<0.05, ** p<0.01 and *** 
p<0.001.
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